GUTS
Price:
$1.98
Market Cap:
$142.94M
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to F...[Read more]
Industry
Biotechnology
IPO Date
2024-02-02
Stock Exchange
NASDAQ
Ticker
GUTS
According to Fractyl Health, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -0.85. This represents a change of 17.49% compared to the average of -0.72 of the last 4 quarters.
The mean historical PE Ratio of Fractyl Health, Inc. Common Stock over the last ten years is -13.05. The current -0.85 PE Ratio has changed 551.58% with respect to the historical average. Over the past ten years (40 quarters), GUTS's PE Ratio was at its highest in in the September 2025 quarter at -0.56. The PE Ratio was at its lowest in in the March 2024 quarter at -26.85.
Average
-13.05
Median
-14.48
Minimum
-20.07
Maximum
-1.31
Discovering the peaks and valleys of Fractyl Health, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0.37%
Maximum Annual PE Ratio = -1.31
Minimum Annual Increase = -83.55%
Minimum Annual PE Ratio = -20.07
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.31 | -83.55% |
| 2023 | -7.94 | -39.74% |
| 2022 | -13.17 | -16.61% |
| 2021 | -15.79 | -21.31% |
| 2020 | -20.07 | 0.37% |
The current PE Ratio of Fractyl Health, Inc. Common Stock (GUTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.47
5-year avg
-11.65
10-year avg
-13.05
Fractyl Health, Inc. Common Stock’s PE Ratio is less than Adverum Biotechnologies, Inc. (-0.48), less than ALX Oncology Holdings Inc. (-0.63), less than Precision BioSciences, Inc. (-0.71), greater than Artiva Biotherapeutics, Inc. (-1.28), less than Sutro Biopharma, Inc. (-0.37), greater than Quince Therapeutics, Inc. (-3.43), less than Metagenomi, Inc. Common Stock (-0.76), greater than Repare Therapeutics Inc. (-1.33), greater than aTyr Pharma, Inc. (-1.07), greater than Biomea Fusion, Inc. (-0.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.48 | $92.06M | |
| -0.63 | $74.28M | |
| -0.71 | $66.54M | |
| -1.28 | $92.66M | |
| -0.37 | $79.86M | |
| -3.43 | $200.45M | |
| -0.76 | $67.21M | |
| -1.33 | $95.84M | |
| -1.07 | $81.11M | |
| -0.90 | $70.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fractyl Health, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Fractyl Health, Inc. Common Stock's PE Ratio?
How is the PE Ratio calculated for Fractyl Health, Inc. Common Stock (GUTS)?
What is the highest PE Ratio for Fractyl Health, Inc. Common Stock (GUTS)?
What is the 3-year average PE Ratio for Fractyl Health, Inc. Common Stock (GUTS)?
What is the 5-year average PE Ratio for Fractyl Health, Inc. Common Stock (GUTS)?
How does the current PE Ratio for Fractyl Health, Inc. Common Stock (GUTS) compare to its historical average?